Ligand-induced conformational changes in the β1-adrenergic receptor revealed by hydrogen-deuterium exchange mass spectrometry

Nat Commun. 2024 Oct 18;15(1):8993. doi: 10.1038/s41467-024-53161-0.

Abstract

G Protein Coupled Receptors (GPCRs) constitute the largest family of signalling proteins responsible for translating extracellular stimuli into intracellular functions. They play crucial roles in numerous physiological processes and are major targets for drug discovery. Dysregulation of GPCRs is implicated in various diseases, making understanding their structural dynamics critical for therapeutic development. Here, we use Hydrogen Deuterium Exchange Mass Spectrometry (HDX-MS) to explore the structural dynamics of the turkey β1-adrenergic receptor (tβ1AR) bound with nine different ligands, including agonists, partial agonists, and antagonists. We find that these ligands induce distinct dynamic patterns across the receptor, which can be grouped by compound modality. Notably, full agonist binding destabilises the intracellular loop 1 (ICL1), while antagonist binding stabilises it, highlighting ICL1's role in G protein recruitment. Our findings indicate that the conserved L72 residue in ICL1 is crucial for maintaining receptor structural integrity and stabilising the GDP-bound state. Overall, our results provide a platform for determining drug modality and highlight how HDX-MS can be used to dissect receptor ligand interaction properties and GPCR mechanism.

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / chemistry
  • Adrenergic beta-1 Receptor Antagonists / metabolism
  • Adrenergic beta-1 Receptor Antagonists / pharmacology
  • Animals
  • Deuterium Exchange Measurement / methods
  • HEK293 Cells
  • Humans
  • Hydrogen Deuterium Exchange-Mass Spectrometry* / methods
  • Ligands
  • Protein Binding
  • Protein Conformation
  • Receptors, Adrenergic, beta-1* / chemistry
  • Receptors, Adrenergic, beta-1* / metabolism
  • Turkeys

Substances

  • Receptors, Adrenergic, beta-1
  • Ligands
  • Adrenergic beta-1 Receptor Antagonists